BRPI0714761B8 - formulações compreendendo compostos cíclicos - Google Patents
formulações compreendendo compostos cíclicosInfo
- Publication number
- BRPI0714761B8 BRPI0714761B8 BRPI0714761A BRPI0714761A BRPI0714761B8 BR PI0714761 B8 BRPI0714761 B8 BR PI0714761B8 BR PI0714761 A BRPI0714761 A BR PI0714761A BR PI0714761 A BRPI0714761 A BR PI0714761A BR PI0714761 B8 BRPI0714761 B8 BR PI0714761B8
- Authority
- BR
- Brazil
- Prior art keywords
- independently
- protonated
- active agent
- cyclic
- dil
- Prior art date
Links
- 150000001923 cyclic compounds Chemical class 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 3
- 125000003277 amino group Chemical group 0.000 abstract 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical group NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyclic sugars Chemical class 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyesters Or Polycarbonates (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06020286.8 | 2006-09-27 | ||
| EP06020286A EP1905454A1 (en) | 2006-09-27 | 2006-09-27 | Formulations comprising cyclic compounds |
| PCT/EP2007/008442 WO2008037484A2 (en) | 2006-09-27 | 2007-09-27 | Formulations comprising cyclic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0714761A2 BRPI0714761A2 (pt) | 2013-07-02 |
| BRPI0714761B1 BRPI0714761B1 (pt) | 2021-03-23 |
| BRPI0714761B8 true BRPI0714761B8 (pt) | 2021-05-25 |
Family
ID=37728182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0714761A BRPI0714761B8 (pt) | 2006-09-27 | 2007-09-27 | formulações compreendendo compostos cíclicos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8513188B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1905454A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5335677B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN101557829A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007302270B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0714761B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2664568C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2691736T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL197760A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008037484A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2332929A1 (en) * | 2009-11-25 | 2011-06-15 | ArisGen SA | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
| CA2782056C (en) | 2009-11-25 | 2021-03-09 | Arisgen Sa | Mucosal delivery of peptides |
| EP2526971A1 (en) * | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
| CN102863358B (zh) * | 2012-09-20 | 2014-02-12 | 华中农业大学 | 具有除草活性的化合物及其制备方法 |
| EP3000811B1 (en) * | 2014-09-24 | 2017-11-08 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Crown Ether Complexes and Methods for Poducing the Same |
| US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| CN108658264B (zh) * | 2018-04-17 | 2021-05-25 | 唐山师范学院 | 多支化聚环氧琥珀酸衍生物阻垢缓蚀剂的制备及其应用方法 |
| CN113527672B (zh) * | 2020-03-30 | 2022-09-20 | 复旦大学 | 一种胍基衍生物及其基因递释系统 |
| CN116178887B (zh) * | 2023-02-16 | 2024-10-29 | 东华大学 | 一种可降解快递袋材料及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2923787A1 (de) | 1979-06-12 | 1980-12-18 | Max Planck Gesellschaft | Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel |
| US4474753A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Topical drug delivery system utilizing thermosetting gels |
| CH666813A5 (de) * | 1985-12-04 | 1988-08-31 | Dean Hsieh | Arzneimittel zur transdermalen verabreichung. |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| JP4713798B2 (ja) * | 1999-06-29 | 2011-06-29 | マンカインド コーポレイション | ペプチドおよびタンパク質の薬学的因子の精製および安定化 |
| US6825314B1 (en) | 1999-09-20 | 2004-11-30 | Amato Pharmaceutical Products, Ltd. | Process for the preparation of cyclic lactic acid oligomers |
| JP2005538035A (ja) * | 2001-12-11 | 2005-12-15 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | グアニジニウム輸送試薬および結合体 |
| JP2006232909A (ja) * | 2005-02-23 | 2006-09-07 | Tokai Univ | 環状オリゴ乳酸 |
-
2006
- 2006-09-27 EP EP06020286A patent/EP1905454A1/en not_active Withdrawn
-
2007
- 2007-09-26 CN CNA2007800425762A patent/CN101557829A/zh active Pending
- 2007-09-27 EP EP07818525.3A patent/EP2068934B8/en not_active Not-in-force
- 2007-09-27 ES ES07818525.3T patent/ES2691736T3/es active Active
- 2007-09-27 BR BRPI0714761A patent/BRPI0714761B8/pt not_active IP Right Cessation
- 2007-09-27 US US12/443,327 patent/US8513188B2/en not_active Expired - Fee Related
- 2007-09-27 WO PCT/EP2007/008442 patent/WO2008037484A2/en not_active Ceased
- 2007-09-27 CA CA2664568A patent/CA2664568C/en active Active
- 2007-09-27 AU AU2007302270A patent/AU2007302270B2/en not_active Ceased
- 2007-09-27 JP JP2009529613A patent/JP5335677B2/ja not_active Expired - Fee Related
- 2007-09-27 CN CN200780043437.1A patent/CN101541346B/zh not_active Expired - Fee Related
-
2009
- 2009-03-23 IL IL197760A patent/IL197760A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL197760A (en) | 2016-10-31 |
| CN101541346B (zh) | 2014-07-02 |
| JP5335677B2 (ja) | 2013-11-06 |
| EP2068934A2 (en) | 2009-06-17 |
| IL197760A0 (en) | 2009-12-24 |
| EP2068934B1 (en) | 2018-07-18 |
| CN101541346A (zh) | 2009-09-23 |
| WO2008037484A2 (en) | 2008-04-03 |
| CN101557829A (zh) | 2009-10-14 |
| AU2007302270A1 (en) | 2008-04-03 |
| BRPI0714761A2 (pt) | 2013-07-02 |
| EP1905454A1 (en) | 2008-04-02 |
| CA2664568C (en) | 2015-11-24 |
| EP2068934B8 (en) | 2018-09-05 |
| BRPI0714761B1 (pt) | 2021-03-23 |
| WO2008037484A3 (en) | 2008-12-18 |
| US20100137188A1 (en) | 2010-06-03 |
| CA2664568A1 (en) | 2008-04-03 |
| US8513188B2 (en) | 2013-08-20 |
| ES2691736T3 (es) | 2018-11-28 |
| JP2010504934A (ja) | 2010-02-18 |
| AU2007302270B2 (en) | 2014-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0714761B8 (pt) | formulações compreendendo compostos cíclicos | |
| RU2009137607A (ru) | Композиции и наборы для лечения гриппа | |
| UY29410A1 (es) | Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones. | |
| BR0111126A (pt) | Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos | |
| BR0208652A (pt) | Composição parenteral reconstituìvel contendo um inibidor de cox-2 | |
| BRPI0409185A (pt) | formulações veterinárias anti-helmìnticas tópicas | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0516825A (pt) | inibição da protease ns3-ns4a do vìrus da hepatite c (vhc) | |
| BR0314236A (pt) | Formulação de oligonucleotìdeo, composição farmacêutica, kit, composto antiviral, preparação de oligonucleotìdeo e métodos para seleção de um oligonucleotìdeo antiviral para uso como um agente antiviral, para profilaxia ou tratamento de uma infecção viral em um paciente, para tratamento profilático de câncer causado por oncovìrus, para identificação de um composto que altera a ligação de um oligonucleotìdeo a pelo menos um componente viral, para purificação da ligação de oligonucleotìdeos a pelo menos um componente viral e para enriquecimento de oligonucleotìdeos a partir de um agrupamento de oligonucleotìdeos | |
| BRPI0819319B8 (pt) | análogos de aminoglicosídeo antibacteriano | |
| EA200400664A1 (ru) | Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii | |
| NO20025999D0 (no) | Klart, vandig anestetisk preparat | |
| BRPI0411098A (pt) | benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos | |
| BR9808521A (pt) | Moléculas que apresentam um grande número de partes ativas. | |
| AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
| BRPI0513858B8 (pt) | compostos de benziltriazolona como inibidores não-nucleosídeos da transcriptase reversa, seu processo de preparação, seu uso e composição farmacêutica que os compreende | |
| NO20071321L (no) | Anti-inflammatoriske midler | |
| BRPI0417161A (pt) | compostos, composições farmacêuticas, e, uso de um composto | |
| FR2903107B1 (fr) | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique | |
| BRPI0315958B8 (pt) | composto, composição farmacêutica, processo para a preparação de um composto, novos intermediários e uso do composto | |
| BRPI0518096A (pt) | composto, composição farmacêutica, uso de um composto para a preparação de um medicamento para o tratamento de uma condição resultante de uma anormalidade na produção de óxido nìtrico, uso de um composto para a preparação de um medicamento para o tratamento da dor em um indivìduo com necessidade do mesmo e uso de um composto para a preparação de um medicamento para o tratamento de inibição da dimerização de inos | |
| TW200736189A (en) | Indene derivatives, their preparation and use as medicaments | |
| MX393201B (es) | Inhibidores novedosos de glutaminil ciclasa y el uso de los mismos en el tratamiento de diversas enfermedades | |
| BRPI0506496B8 (pt) | composição farmacêutica com tolerância melhorada no local de injeção compreendendo sulfobutiléter-ß-ciclodextrina e seu uso no tratamento de êmese composição farmacêutica com tolerância melhorada no local de injeção compreendendo sulfobutiléter-ß-ciclodextrina e seu uso no tratamento de êmese composição farmacêutica com tolerância melhorada no local de injeção compreendendo sulfobutiléter-ß-ciclodextrina e seu uso no tratamento de êmese | |
| BRPI0713439A2 (pt) | derivados aminados de b-homoandrostanos e b-heteroandrostanos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: CAPSUGEL BELGIUM (BE) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/03/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/09/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 17A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2794 DE 23-07-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |